Behavioral Diagnostics Inc Profile last edited on: 1/24/2018
CAGE: 5GL32
UEI: C8DQNL9C97V8
Business Identifier: Genetic research for identifying, managing, and preventing substance abuse 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
15 Prospect Place
Iowa City, IA 52246
Iowa City, IA 52246
| (319) 358-8602 |
| N/A |
| N/A |
Location: Single
Congr. District: 01
County: Johnson
Congr. District: 01
County: Johnson
Public Profile
Behavioral Diagnostics Inc. uses years of experience in genetic research to help identify, manage, and even prevent substance abuse. The company was founded based on the idea of commercializing research conducted at the University of Iowa that showed that substance use and abuse leads to specific recognizable genetic chemical changes. Their vision is that by fully understanding how different substances alter someones genetic profile, they can increase the quality of treatment for substance abuse problems, as well as definitively detect substance use when appropriate.
Hide Venture Information
Stage:
Pre-Clinical
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2024 | 2 | NIH | $1,870,732 | |
| Project Title: An Improved Epigenetic Algorithm for Guiding Low Dose CT Lung Cancer Screening | ||||
| 2022 | 1 | NIH | $281,362 | |
| Project Title: A Saliva Based Epigenetic Assay for Assessing Vitamin B9 and B12 Status | ||||
| 2021 | 1 | NIH | $395,569 | |
| Project Title: A DNA Methylation Test for Guiding Lung Cancer Screening | ||||
| 2019 | 1 | NIH | $224,999 | |
| Project Title: Quantitative Biomarkers for Monitoring Alcohol Abstinence | ||||
| 2018 | 1 | NIH | $223,260 | |
| Project Title: A Saliva Based Kit for the Epigenetic Assessment of Heavy Alcohol Intake | ||||
Key People / Management
Anup Madan -- Co-Founder
Terry W Osborn
Robert A Philibert -- Co-Founder
Terry W Osborn
Robert A Philibert -- Co-Founder
Company News
There are no news available.
